Health
Regeneron’s Antibody Combination Therapy Reduces COVID-19 Mortality Risk – BioPharm International
RECOVERY trial results have shown that Regeneron’s investigational antibody combination therapy reduces the mortality risk for…
Results of the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial have shown that Regenerons investigational antibody combination therapy reduces the mortality risk for hospitalized patients with severe COVID-19 whose immune response has not started…
Continue Reading
-
General24 hours agoNew US tariffs on semiconductors coming ‘over the next week’, Donald Trump says
-
Noosa News22 hours agoLockyer Valley man accused of killing wife allegedly staged mower crash scene, court hears
-
Noosa News21 hours agoFather and son from the UK killed, local man in critical condition after Seventeen Seventy beach tragedy
-
General21 hours agoSearch for driver in Parramatta River after car hit woman before going into water